Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia

NCT04964505 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: Uproleselan
DRUG: Venetoclax

Sponsor

Brian Jonas

Collaborators

[object Object]
[object Object]